DIRECTOR DEALINGS SUMMARY: Strategic Mineral Chief Buys At Premium

LONDON (Alliance News) - The following is a summary of director dealings reported in London on Monday.
----------
Strategic Minerals said Chief Executive John Peters acquired 3 million shares in the company for 0.6 pence per share on Friday. The purchase pushes Peters' holding in the company to 8.7 million shares, or 0.98% of its issued share capital.

Strategic Minerals shares closed up 15% on the news Monday to 0.432p, having touched 0.50p earlier in the day.

"I wanted to take part in the recent share placement but was unable to as we were in a close period. My purchase, at significantly above market, reflects my continued confidence in the company, its ability to complete the Tatu project, and the price at which the placing was carried out," said Peters.

Strategic Minerals shares were lifted last week when it said the government of New Zealand has confirmed the ownership of the mining licence for the Tatu coal project has been transferred following the company's recent acquisition of King Country Mining Ltd. At the end of March, Strategic Minerals had reached a deal to acquire a 51% stake in King County, which could eventually rise to 100% if the company exercises an option.

Earlier in the month, Peters had caused concern and confusion among shareholders, only three days after the company appointed its new Chairman Alan Brookes, by releasing a statement that said it was "imperative" to acquire more assets, because the Cobre mine in New Mexico was not sufficient to cover its overheads.

Peters said at the time that while the Cobre mine remained profitable, it was not sufficient to meet its corporate overheads, but then released another statement that said the release had been "misinterpreted".
----------
Ergomed said Chief Executive Miroslav Reljanovic, the company's founder, sold 4 million shares at 170p each, worth GBP6.8 million.

The pharmaceutical company said Reljanovic also has agreed to grant an option over 176,470 shares from his own holding to Chief Financial Officer Neil Clark and Chief Business Officer Andrew Mackie at an exercise price of GBP0.01. Half of the shares will be exercisable immediately and half will be subject to a year vesting period.

Following the transactions, Reljanovic remains interested in 17.2 million shares in Ergomed, representing approximately 60% of its issued share capital. A medical doctor, Reljanovic founded Ergomed in 1997.

"It has always been Ergomed's intention to reduce Dr Reljanovic's founder holding and thereby increase liquidity and broaden the institutional shareholder base. Dr Reljanovic remains committed to leading delivery of the company's strategy and we are excited about the future potential in the business," Chairman Rolf Stahel said in a statement.

Shares in Ergomed closed down 6.9% at 170.00p on Monday.
----------
Share said Marianne Oldham, a person connected to Executive Chairman Gavin Oldham, bought 544 shares in the company at 33.145p on July 6. Following the transaction Marianne Oldham holds 2.3 million shares in the company, or a 1.62% interest, and Gavin Oldham hold 98.9 million shares, or a 68.85% interest in the company. Shares in Share closed down 1.2% at 31.12p Monday.
----------
Consultancy and technology products company Imaginatik said it raised GBP120,000 via a share subscription. The company issued 2 million shares at 6p per share to raise the funds, in a process run by Daniel Stewart & Co. Shares in Imaginatik closed down 1.2% to 6.30p Monday.

The subscription was done to meet market demand for Imaginatik shares, it said, and the proceeds will be used for additional working capital.

Matt Cooper, non-executive chairman of Imaginatik, participated in the subscription, taking 250,000 of the shares on offer. That raises his stake in the company to 22.9 million shares, or 27.07% of the enlarged issued share capital of the business. In addition to Cooper, Non-Executive Director Simon Charles subscribed for 100,000 of the shares, bringing his total interest in Imaginatik to 2.5 million shares, or a 2.96% stake.
----------
Advanced Oncotherapy said Non-Executive Director Enrico Vanni bought 1 million shares in the company for 7.9p per share on Tuesday last week. Following the transation, Vanni holds 14.05 million shares in the company, representing a 1.02% stake. Vanni joined the board of the company, which develops proton therapy systems for cancer treatment, in October 2013 and also is currently a vice-chairman on the board of director at Swiss pharmaceutical giant Novartis. Shares in Advanced Oncotherapy closed down 1.6% on Monday at 8.24p.
----------
Chariot Oil and Gas said Non-Executive Director William Trojan purchased 74,820 shares at a price of 8.5p per share last Friday. Following the transaction, Trojan holds a total of 266,633 shares in the company, representing a 0.10% stake. Under the company's non-executive directors' restricted share unit plan, Trojan will receive a matching share award of a further 74,820 shares over the next three years provided he retains all of the shares he has just purchased. Chariot shares closed up 0.4% to 8.33 pence per share Monday.
----------
Infrastructure India said Chief Executive Sonny Lulla bought 90,000 shares in the company for 18 pence per share on Friday. Lulla now owns 790,000 shares in the company, or 0.12% of its issued share capital. Shares in the India-focused infrastructure investor closed up 11% at 20p Monday.
----------
NewRiver Retail late Friday said that four directors at the company, including the chief executive, bought shares under a placing at 300p each. Shares in NewRiver closed down 0.5% at 322.00p on Monday. Chief Executive David Lockhart bought 42,000 shares and now has a holding of 1.7 million shares representing 1% of the company's shares. Property Director Alan Lockhart bought 33,333 shares and holds 262,560 shares. Finance Director Mark Davies bought 12,000 shares and holds 30,000 shares. Executive Director Nicholas Sewell bought 3,333 shares and now has a holding of 114,833 shares.
----------
By Tom Waite; thomaslwaite@alliancenews.com; @thomaslwaite

Copyright 2015 Alliance News Limited. All Rights Reserved.